Laird Superfood® to Participate in 37th Annual Roth 2025 Conference March 17, 2025
37th Annual Roth 2025 Conference – March 17-18, 2025Type: 7 p.m. ET fireside chatPresentation: March 17, 2025, 7 p.m. ET
A live cast is available at the following location: https://event.summitcast.com/view/YsA9Ty4sRyad4m3F6KNZ7x/VE7q2Vr9pzq7uE9vpAPeV4
The presentation materials will later be available on the Investor Relations section of the Company's website at www.lairdsuperfood.com.
During the presentation, Laird Superfood's leadership team will discuss the Company's continued innovation in the clean, functional food space, recent product launches, and strategic growth initiatives designed to expand market presence and drive shareholder value.
"We appreciate the opportunity to share Laird Superfood's vision and growth strategy with the investment community at the Roth Conference," said Jason Vieth, Chief Executive Officer of Laird Superfood. "As consumer demand for clean, minimally processed products continues to accelerate, we remain focused on delivering innovative superfood solutions that support daily wellness while driving sustainable business growth."
ABOUT LAIRD SUPERFOOD®Laird Superfood is a clean plant-based food brand that offers superfood products to help fuel, energize, and improve performance. The company was founded in 2015 by leading big wave surfer Laird Hamilton who set out to find a better morning routine to improve and sustain performance while out catching waves. He created superfood creamers with a blend of plant-based fats and other real-food ingredients that not only sustain his energy but also taste great in his morning coffee. Alongside his wife, former professional beach volleyball icon, best-selling author and fitness expert, Gabby Reece, the brand has expanded to instant lattes, coffees, bars, and prebiotic daily greens. Laird Superfood is based on the idea that people deserve simple ingredient, minimally processed foods can help fuel you from sunrise to sunset.
PRESS CONTACTAva D'Ambrosioava@stanton-company.com949-533-7501
Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding our strategic initiatives, growth strategy, market expansion plans, new product development, financial projections, and anticipated consumer trends.
These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the effects of competition in our industry; our ability to attract new customers and retain existing customers; our ability to effectively introduce new products and manage product transitions; changes in consumer preferences; fluctuations in the cost and availability of raw materials; supply chain disruptions; our dependence on a limited number of suppliers; our ability to maintain favorable relationships with distributors; our ability to maintain our corporate culture; our ability to manage our growth effectively; and the other important factors discussed under the caption "Risk Factors" in our most recent Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission.
These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/laird-superfood-to-participate-in-37th-annual-roth-2025-conference-march-17-2025-302403666.html
SOURCE Laird Superfood
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Thompson Davis Reaffirms Their Buy Rating on GXO Logistics (GXO)
Thompson Davis analyst maintained a Buy rating on GXO Logistics on August 8 and set a price target of $65.00. The company's shares closed last Friday at $50.33. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In addition to Thompson Davis, GXO Logistics also received a Buy from J.P. Morgan's Brian Ossenbeck in a report issued on August 7. However, on the same day, Loop Capital Markets maintained a Hold rating on GXO Logistics (NYSE: GXO). The company has a one-year high of $63.33 and a one-year low of $30.46. Currently, GXO Logistics has an average volume of 1.29M.
Fast Company
2 hours ago
- Fast Company
My employee is bad at his job but keeps saying he's doing great
columnist Alison Green answers questions about workplace and management issues—everything from how to deal with a micromanaging boss to how to talk to someone on your team about body odor. A reader asks: I recently hired a new administrative employee. His job is to answer phones, greet guests, and complete various tasks I assign to him. His customer service skills are strong, but his attention to detail is very weak. I have given him a lot of feedback and training, but he continues to make basic mistakes and misses almost every deadline I give him. But he is constantly telling me how great a job he's doing. He routinely tells me things like, 'You are going to be so happy when I show you what I've done for you!' or 'You are going to love me—I am making your life so much easier!' and then hands me a report that I have to spend a half-hour correcting. Yesterday, I told him to follow up with me when he completes tasks because I would rather he proactively inform me than wait for me to ask. His response: 'As you know, I always complete tasks immediately [ this is untrue ] but I didn't know you needed me to remind you of that. No problem at all!' This behavior is really grating on me. His work product hasn't improved and I'm starting to feel like he's trying to manipulate me into not giving him corrections. I'm starting to struggle giving him feedback because I feel like he ignores me and I'm letting that affect my interactions with him. Have I already arrived at the 'this needs to improve or else' conversation? He started just two months ago. I want to give him time to learn and grow, but my patience is zapped. Green responds: I'm sorry, I laughed out loud at 'As you know, I always complete tasks immediately [ this is untrue ].' You do need to have the 'this needs to improve or else' conversation. You've given him very basic feedback over and over, he's not improving, and he misses almost every deadline you give him. His overhyping of his own work makes this more concerning. If you could see that he was taking your feedback seriously, he understood that his work isn't where it needs to be, and he was working hard to incorporate your feedback, I'd say sure, give him some time to work on mastering the job. But when he's ignoring your feedback and telling you his work is superb when you've clearly told him it's not, that's a serious problem, and not the sort that time usually helps with. However! There's potentially some room for hope if you haven't been completely clear with him. When you've given him feedback and talked about mistakes, have you been clear that the work isn't at the level you need and that the pattern of mistakes is serious? And when he misses deadlines, have you told him clearly that it can't keep happening? (For example: 'This was due yesterday—what happened?' Followed by, 'It's really important that you turn in work by the agreed-upon deadline or tell me ahead of time if you're worried about your ability to do that.') If you haven't done those things, it's possible that this could turn this around. A lot of managers in your situation think, 'But I shouldn't need to do that! He should know that missing a deadline is a big deal, and that he needs to take feedback seriously.' And indeed, he should. But many employees miss the cues that managers think are obvious—and when you're frustrated with someone, the first step is to make sure that you've been really clear about the expectations you need them to meet. (In fact, whenever you're feeling frustrated with an employee, that's a flag to check how clear you've been.) If you've done those things and this is still happening, then yes, it's time for a serious conversation where you explain you can't keep him in the job if you don't see significant improvement on these fronts quickly. Interestingly, I think you can do all of this without directly addressing the 'I'm amazing' comments. By addressing the crux of the problem—his work is not what you need it to be—he'll probably get the message that his self-hype isn't in line with the reality. If he doesn't, that's not a great sign about how well he's processing your message. That said, if you want to address it, you can! You could say, 'I was surprised to hear you say you always complete tasks immediately when I've shared my concern about a number of missed deadlines recently.' Or you can take the hype as statements of his intentions rather than what he's actually done. For example, with his 'I am making your life so much easier!' comment, you could refer back to that later with something like, 'I know you want to make my life easier and I appreciate that—that's what I want from your role as well. When you give me a report with errors that I have to spend half an hour correcting, that's not happening. I need you to double-check your work before it comes to me so that you're spotting and correcting your own errors and I don't need to fix anything when it comes my way.' But I think if you keep the focus on the gap between the work he's producing and the work you need—and just consider the self-hype a strange and even amusing eccentricity —you'll figure out pretty quickly if he can succeed in the job or not, and that's what really matters.
Business Insider
3 hours ago
- Business Insider
‘Time to Double Down,' Says Top Investor About Novo Nordisk Stock
It has been a rough few seasons for Novo Nordisk (NYSE:NVO) investors, as the company's share price has tumbled some 60% over the past twelve months. Though Novo Nordisk remains the dominant player in the burgeoning GLP-1 market, worries over a complex regulatory environment, lowered guidance, and increasing competition, among other concerns, have whittled away some of its support. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. And yet, the company's Q2 2025 earnings call last reflected rising sales of 18% during the first half of the year, increased operating profits of 29% for the first six months as well, and advancements with strategic R&D initiatives including an oral weight loss medicine. The market responded with a warmth that has been missing, and NVO's share price has increased by double digits since the earnings call. Top investor James Foord thinks a turnaround is indeed beckoning. 'The recent stock correction presents a rare long-term buying opportunity, supported by a strong pipeline, manufacturing expansion, and international momentum,' asserts the 5-star investor, who is among the top 2% of TipRanks' stock pros. The investor notes that the company succeeded in delivering strong numbers in Q2, with GLP-1 drugs leading the way. While sales for Ozempic – used to treat Type 2 diabetes – jumped by 35%, the Wegovy weight loss drug saw its sales increase by 67%. And it's not just the North American market which is gaining steam, points out Foord. Japan experienced a 91% increase in GLP-1 drugs in Q2. It is this dominance in the GLP-1 market which gives Foord plenty of bullish confidence in NVO going forward – especially as Wegovy aims for a 2026 tablet form. 'Novo has shown superior performance in their latest pill version of Wegovy versus Lily, and this is very encouraging,' adds Foord. With the company spending billions of dollars to increase production capabilities, including in North Carolina, and the potential for GLP-1 drugs to be used for additional morbidities such as Alzheimer's and cardiovascular disease, the investor predicts NVO is on the road to recovery. 'With new facilities coming online, oral drugs in development, and global demand still exploding, I see NVO not only rebounding but potentially doubling in the next few years,' concludes Foord. 'I'm buying more.' No surprise here, Foord is rating NVO a Strong Buy. (To watch James Foord's track record, click here) Though slightly more tempered, Wall Street is also optimistic about NVO. With 2 Buy ratings and 3 Holds, NVO enjoys a Moderate Buy consensus rating. Its 12-month average price target of $71.75 has an upside north of 40%. (See NVO stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
